Phenazolam

Phenazolam
Clinical data
Trade names	(none, designer drug)
Legal status
Legal status	CA: Schedule IV; DE: NpSG (Industrial and scientific use only); UK: Class C ; Illegal in Serbia and Italy;
Identifiers
	IUPAC name 8-bromo-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine;
CAS Number	87213-50-1 ;
PubChem CID	1032830;
ChemSpider	887985;
UNII	2AVB9ZZ4ZS;
ChEMBL	ChEMBL1451229;
CompTox Dashboard (EPA)	DTXSID10236191;
Chemical and physical data
Formula	C17H12BrClN4
Molar mass	387.67 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=NN=C2N1C3=C(C=C(C=C3)Br)C(=NC2)C4=CC=CC=C4Cl;
	InChI InChI=1S/C17H12BrClN4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3; Key:BUTCFAZTKZDYCN-UHFFFAOYSA-N;

Phenazolam, (Clobromazolam, DM-II-90, BRN 4550445) is a benzodiazepine derivative which acts as a potent sedative and hypnotic drug. It was first invented in the early 1980s,^[2] but was never developed for medical use. It has been sold over the internet as a designer drug, first being identified in seized samples by a laboratory in Sweden in March 2016.^[3]^[4]